Uwe Junker

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Use of anti-sclerostin antibodies in the treatment of osteogenesis...
- Patent number 12,173,058
- Issue date Dec 24, 2024
- MEREO BIOPHARMA 3 LIMITED
- Uwe Junker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of anti-sclerostin antibodies in the treatment of osteogenesis...
- Patent number 10,961,305
- Issue date Mar 30, 2021
- MEREO BIOPHARMA 3 LIMITED
- Uwe Junker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20240400666
- Publication date Dec 5, 2024
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20230365669
- Publication date Nov 16, 2023
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20210253687
- Publication date Aug 19, 2021
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20210253684
- Publication date Aug 19, 2021
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20200179509
- Publication date Jun 11, 2020
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20200123242
- Publication date Apr 23, 2020
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...
- Publication number 20190330322
- Publication date Oct 31, 2019
- MEREO BIOPHARMA 3 LIMITED
- Uwe JUNKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR IMPROVING IMPLANT OSSEOINTEGRATION
- Publication number 20130138221
- Publication date May 30, 2013
- Novartis AG
- Uwe Junker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Use of anti-sclerostin antibodies in the treatment of osteogenesis...

Use of anti-sclerostin antibodies in the treatment of osteogenesis...

Patents Applicationslast 30 patents

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS...

METHODS AND COMPOSITIONS FOR IMPROVING IMPLANT OSSEOINTEGRATION